Nektar Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops a pipeline of drug candidates that utilizes its PEGylation and polymer conjugate technology platforms that are designed to develop molecular entities.
| Website: | www.nektar.com |
| Email: | Investors@nektar.com |
| Main Phone: | +1 415 482-5300 |
| Address: | 455 Mission Bay Boulevard South |
| State: | CA |
| City / Town: | San Francisco |
| Country: | USA |
| Postal Code: | 94158 |
| Exchange: | NGS |
| Employees: | 425 |
| NAICS: | Pharmaceutical P |
| Last Price 18.33 | Change $ -0.28 | Change % -1.50 | Tick N/A |
| Bid 10.46 | Bid Size 100.00 | Ask 19.16 | Ask Size 100.00 |
| Open 18.43 | High 18.85 | Low 18.30 | Prev Close 18.61 |
| Last Trade | Volume 509,025 | 52 Wk Hi 24.88 | 52 Wk Low 11.41 |
| Market Cap 2.9 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 156,327,530.00 | EPS (TTM) -1.41 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 20 | 115 |
| Number of Buys | 10 | 63 |
| Number of Sells | 10 | 52 |
| Net Activity | 164764 | 231759 |
| Last 10 Buys | Shares |
|---|---|
| Dennis L. Winger | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Stephen K. Doberstein | 1,000 |
| John Nicholson | 1,000 |
| Jillian B. Thomsen | 1,000 |
| Gil M. Labrucherie | 1,000 |
| Ivan P. Gergel | 1,000 |
| Howard W. Robin | 1,000 |
| Maninder Hora | 1,000 |
| Robert B. Chess | 1,000 |
| Robert B. Chess | 1,000 |
| Robert B. Chess | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 21 | 20 | 20 | 25 |
| Low Target Price Estimate | 14 | 14 | 14 | 14 |
| Mean Target Price Estimate | 18.33 | 17.67 | 17.67 | 19.33 |
| Standard Deviation | 2.73 | 2.42 | 2.42 | 3.56 |
| Date of Most Recent Estimate | 08/12/16 | 08/04/16 | 07/27/16 | 08/22/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-17 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 116 | 2016-08-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2016-08-03 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1.38 | 1.38 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
